Search for Stocks /

Bayer CropScience Ltd Q3 FY26: ₹11,062 Million Revenue, ₹957 Million Profit, 180% QoQ PAT Jump — But Is 32x P/E Justified?


1. At a Glance – The German Giant in Indian Kheti Mode

Bayer CropScience Ltd is currently priced at ₹4,791 with a market cap of ₹21,533 Cr. In the last 3 months, the stock is up 7.04%, despite agri cycles behaving like moody monsoons.

Q3 FY26 numbers (Quarterly Results – locked) show revenue of ₹11,062 million (₹1,106 Cr) and profit of ₹957 million (₹95.7 Cr). That’s a 180% QoQ jump in PAT.

ROCE stands at a spicy 24.8%, ROE at 20%, debt-to-equity is a microscopic 0.03, dividend yield is 2.61%, and stock P/E is 32.1 — slightly above industry PE of 28.

Sounds like a disciplined German engineer managing Indian crops.

But wait.

Five-year sales growth? 8.68%.
Five-year profit growth? Basically flat.
Inventory days? 319 last year.

So what are we looking at — a steady agri compounder or a cyclical agrochemical rollercoaster wearing a lab coat?

Let’s dig in.


2. Introduction – Seeds, Sprays & Corporate Surprises

Bayer entered India in 1958. That’s older than half the investors reading this.

The company operates in:

  • Crop Protection (66% revenue mix FY25)
  • Corn Seeds (17%)
  • Others (17%)

In 2019, after the global acquisition of Monsanto, Indian operations saw the merger approved by NCLT. That integration brought scale, technology, and probably some boardroom drama.

Now fast forward to FY26:

  • Q2 FY26 revenue ₹15,534 million
  • Q3 FY26 revenue ₹11,062 million
  • Interim dividend ₹90 per share in Q2

That’s not small change.

But here’s the thing about agri companies — they are seasonal creatures. One quarter you’re a hero. Next quarter you’re praying for rain.

And Bayer is no exception.

The company is working with 1,500+ FPOs and 75+ food value chain partnerships impacting nearly 5 lakh smallholders. That’s scale.

But investors don’t get emotional about smallholders.

They care about margins, cash flows, and whether GST authorities are sending love letters.

Speaking of which… penalties worth ₹1 million and ₹103 million were imposed for earlier financial years. Later, some were set aside by CESAT.

Regulatory drama is part of the package.

Now the real question — are we paying 32x earnings for stability or brand

Read Full 16 Point breakdown. Continue reading →
Members get full access to every article.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →